Enhancing Ozempic's Effectiveness by Targeting Specific Neurons
Adjusting melanocortin proteins in the brain can significantly enhance the effectiveness of GLP-1 diabetes and weight-loss drugs, leading to more substantial weight loss and reduced feeding in mice without additional side effects. This discovery, if confirmed in humans, could improve treatment outcomes for diabetes and obesity.